U.S. Virgin Islands among markets for recalled IV tubing with discoloration

Intravenous tubing that reached the U.S. Virgin Islands has been subject to a federal recall after ICU Medical received reports of black specks and discoloration appearing inside drip chambers used to administer fluids and medications.

On October 5, the Food and Drug Administration assigned the recall a Class II designation, which means a product may cause temporary or medically reversible adverse health consequences, or the probability of serious adverse health consequences is considered remote. ICU Medical initiated the action on May 12, with the FDA adding it to its public database on September 11.

The recalled items span standard IV administration sets and specialized oncology sets for cancer patients. FDA distribution records confirm the Virgin Islands received shipments, but the agency's public files do not reveal which local hospitals obtained them or in what quantities.

ICU Medical's investigation determined that the dark discoloration was embedded within the polyvinyl chloride material forming the drip chambers. The company found that the discoloration did not penetrate into the fluid pathway carrying medications to patients, did not come loose during normal use, and did not harm the chambers' structural soundness or function.

As of July 16, the manufacturer had not documented any serious injuries or deaths. The FDA's notice, however, flagged one clinical scenario: if a healthcare provider spots dark discoloration and removes the device before treatment begins, the interruption could matter significantly for patients needing rapid infusions or when replacement units are scarce.

On July 28, ICU Medical advised healthcare facilities to keep using the affected products as originally intended and per standard clinical protocols. The company did not require returns and withdrew an earlier call for heightened inspections after concluding the discoloration posed no safety risk.

Staff were instructed to inspect devices before use using routine procedures. Should loose particles appear in the fluid pathway, the device should be set aside and ICU Medical contacted.

The FDA's records do not specify whether Juan F. Luis Hospital on St. Croix, Schneider Regional Medical Center on St. Thomas, or other territorial providers received the affected tubing, or whether any discolored units surfaced locally. How widely the products circulated in the territory remains unclear. The FDA continues to hold the recall actions open.